Corcillum is a diagnostics and digital health company redefining coronary care and research with corSUITE™, an image annotation and multi-physics modelling platform. Using patented algorithms, the coronary physiology module corFLUX™ calculates key metrics, such as virtual FFR, plus a portfolio of up to 50 novel metrics used for the early identification of vessel and plaque instability, independent of plaque morphology or ischemia, that may lead to future acute events. Our mission is to prevent one million AMI’s by 2050; with corSUITE and corFLUX we aim to empower clinicians in the cath lab and radiology suite to improve triage and personalise treatment, while empowering researchers and CROs with a powerful data and digital twin platform built for the AI and high-performance computing era.

Why work with us

• Unique physiology insights: Powered by corFLUX™, delivering not only virtual FFR but also up to 50 novel, patented coronary metrics that identify vessel and plaque instability earlier than existing methods.
• Advancing research & trials: Enable CROs and research organisations with a scalable, high-performance imaging and digital twin platform purpose-built for the AI era.
• Regulatory alignment: Design with SaMD in mind, ensuring readiness for clinical validation and regulatory pathways.
• Partnership-ready: Combine deep clinical, technical, and regulatory expertise with Australian cost effectiveness and a collaborative mindset to accelerate innovation in cardiovascular health.